VGLS Financials 07/15/2014 20:05:49 VG Life Scien

VGLS Financials 07/15/2014 20:05:49
VG Life Sciences Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - 3 - 6
Cost of Revenue - - - -
Gross Profit - 3 - 6
Operating Expenses
Research and Development 563 499 739 499
Sales, General and Admin. 2,320 1,551 2,480 1,535
Non-Recurring Items 874 551 726 543
Other - - 122 90
Operating Income (3,758) (2,599) (4,067) (2,660)
Income From Continuing Operations
Add'l Income/Expense Items (2,496) (582) - (1,669)
Earnings Before Interest and Tax (6,253) (3,181) (4,067) (4,329)
Interest Expense 1,076 3,759 1,425 2,911
Earnings Before Tax (7,329) (6,940) (5,492) (7,240)
Income Tax - - - -
Minority Interest (59) (89) (74) -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (7,270) (6,851) (5,418) (7,240)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (7,270) (6,851) (5,418) (7,240)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (7,270) (6,851) (5,418) (7,240)